Results for tag: "Iloprost"

Iloprost is a synthetic prostacyclin analogue used in the treatment of cardiovascular diseases. It is used to treat pulmonary arterial hypertension (PAH) and Raynaud's phenomenon, a condition characterized by reduced blood flow to the extremities. Iloprost works by relaxing the blood vessels, increasing blood flow and reducing the pressure in the pulmonary arteries. It is administered intravenously or inhaled through a nebulizer. Iloprost is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 1995. It is currently marketed by several pharmaceutical companies, including Bayer, Actelion, and GlaxoSmithKline. Iloprost is also available in generic form. The iloprost market is a rapidly growing one, with the drug being used to treat a variety of cardiovascular diseases. It is a promising treatment option for those suffering from PAH and Raynaud's phenomenon, and its use is expected to increase in the coming years. Companies in the iloprost market include Bayer, Actelion, GlaxoSmithKline, and several generic drug manufacturers. Show Less Read more